Depression following thrombotic cardiovascular events in elderly medicare beneficiaries: risk of morbidity and mortality
- PMID: 20069046
- PMCID: PMC2800999
- DOI: 10.4061/2009/194528
Depression following thrombotic cardiovascular events in elderly medicare beneficiaries: risk of morbidity and mortality
Abstract
Purpose. Depression and antidepressant use may independently increase the risk of acute myocardial infarction and mortality in adults. However, no studies have looked at the effect of depression on a broader thrombotic event outcome, assessed antidepressant use, or evaluated elderly adults. Methods. A cohort of 7,051 community-dwelling elderly beneficiaries who experienced a thrombotic cardiovascular event (TCE) were pooled from the 1997 to 2002 Medicare Current Beneficiary Survey and followed for 12 months. Baseline characteristics, antidepressant utilization, and death were ascertained from the survey, while indexed TCE, recurrent TCE, and depression (within 6 months of indexed TCE) were taken from ICD-9 codes on Medicare claims. Time to death and first recurrent TCE were assessed using descriptive and multivariate statistics. Results. Of the elders with a depression claim, 71.6% had a recurrent TCE and 4.7% died within 12 months of their indexed TCE, compared to 67.6% and 3.9% of those elders without a depression claim. Of the antidepressant users, 72.6% experienced a recurrent TCE and 3.9% died, compared to 73.7% and 4.6% in the subset of selective serotonin reuptake inhibitor (SSRI) users. Depression was associated with a shorter time to death (P = .008) in the unadjusted analysis. However, all adjusted comparisons revealed no effect by depression, antidepressant use, or SSRI use. Conclusions. Depression was not associated with time to death or recurrent TCEs in this study. Antidepressant use, including measures of any antidepressant use and SSRI use, was not associated with shorter time to death or recurrent TCE.
Figures
Similar articles
-
Health care use in depressed, elderly, cardiac patients and the effect of antidepressant use.Am J Health Syst Pharm. 2009 Feb 15;66(4):366-72. doi: 10.2146/ajhp080092. Am J Health Syst Pharm. 2009. PMID: 19202046
-
A secondary analysis of a duration response association between selective serotonin reuptake inhibitor use and the risk of acute myocardial infarction in the aging population.Ann Epidemiol. 2008 Apr;18(4):316-21. doi: 10.1016/j.annepidem.2007.11.004. Epub 2008 Feb 8. Ann Epidemiol. 2008. PMID: 18261924
-
Comparative Effectiveness of Second-Generation Antidepressants in Reducing the Risk of Dementia in Elderly Nursing Home Residents with Depression.Pharmacotherapy. 2016 Jan;36(1):38-48. doi: 10.1002/phar.1680. Epub 2016 Jan 9. Pharmacotherapy. 2016. PMID: 26748455
-
Associations of depression diagnosis and antidepressant treatment with mortality among young and disabled Medicare beneficiaries with COPD.Gen Hosp Psychiatry. 2013 Nov-Dec;35(6):612-8. doi: 10.1016/j.genhosppsych.2013.06.005. Epub 2013 Jul 18. Gen Hosp Psychiatry. 2013. PMID: 23871313
-
Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study.Clin Ther. 2012 Jan;34(1):113-23. doi: 10.1016/j.clinthera.2011.11.024. Epub 2011 Dec 16. Clin Ther. 2012. PMID: 22177545
References
-
- Judd LL. Surveys show that 20–30% of elderly patients exhibit SSD symptomatology. International Medicine World Report. 1997;12:33–34.
-
- Unützer J, Patrick DL, Simon G, et al. Depressive symptoms and the cost of health services in HMO patients aged 65 years and older: a 4-year prospective study. Journal of the American Medical Association. 1997;277(20):1618–1623. - PubMed
-
- Hunkeler EM, Spector WD, Fireman B, Rice DP, Weisner C. Psychiatric symptoms, impaired function, and medical care costs in an HMO setting. General Hospital Psychiatry. 2003;25(3):178–184. - PubMed
-
- Beekman ATF, Deeg DJH, Braam AW, Smit JH, Van Tilburg W. Consequences of major and minor depression in later life: a study of disability, well-being and service utilization. Psychological Medicine. 1997;27(6):1397–1409. - PubMed
-
- McIntyre RS, O'Donovan C. The human cost of not achieving full remission in depression. Canadian Journal of Psychiatry. 2004;49(3, supplement 1):10S–16S. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources